Additionally, in a larger cohort, the adverse prognostic effects of FGFR1 were observed in cases with high proliferation gene signature (PSG) compared to PSGlow, suggesting that FGFR1 has independent adverse prognostic effects on overall survival in MCL patients. The gene discussed is FGFR1; the disease is mantle cell lymphoma.